Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery

NARecruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Ovarian Neoplasm
Interventions
OTHER

Arm A : intraoperative ANI monitoring of nociception

For the experimental group (arm A), the sufentanil doses are adjusted to maintain an ANI between 50 and 70. Morphine doses are adjusted from 0.05 to 0.05 µg / ml. Intraoperative data will be collected for ANI, TIVA and hemodynamics.

OTHER

Arm B : no specific monitoring of nociception

For the control group (arm B), adjustments to the opioid doses are made in relation to the hemodynamic reactions of the patient and the operating times. Intraoperative data will be collected for TIVA and hemodynamics.

Trial Locations (1)

33076

RECRUITING

Institut Bergonié, Bordeaux

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Institut Bergonié

OTHER